In addition, reduced filamin A levels corrected aberrant Tau levels in cells cultured from PSP patients, while transgenic mice carrying human filamin A recapitulated Tau pathology in neurons [35]. The gene discussed is FLNA; the disease is supranuclear palsy, progressive, 1.